Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08IRN
|
||||
Former ID |
DNC004310
|
||||
Drug Name |
2,4,5-Triarylimidazole analogue
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551278] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H20FN5O2
|
||||
Canonical SMILES |
CC(C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)<br />N(C(=O)N)O
|
||||
InChI |
1S/C23H20FN5O2/c1-14(29(31)23(25)30)15-2-4-18(5-3-15)22-27-20(16-6-8-19(24)9-7-16)21(28-22)17-10-12-26-13-11-17/h2-14,31H,1H3,(H2,25,30)(H,27,28)
|
||||
InChIKey |
JVMAHSCWJIZBJE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of human 5-lipoxygenase | Target Info | Inhibitor | [551278] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.